Related Experiment Videos

[Hemolytic anemia and consumption coagulopathy as a paraneoplastic syndrome in adenocarcinoma]

R Misera, J T Fischer, H J Reimers

Die Medizinische Welt

|August 14, 1981

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia.

Leukemia·2005

Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.

Annals of hematology·2004

Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea.

Leukemia·2003

Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2002

[Carbamazepine poisoning caused by confusing the drugs].

Deutsche medizinische Wochenschrift (1946)·2000

Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML).

Annals of hematology·2000

See all related articles